Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes.
Jing H, Tang Y, Wang ZZ, Wei R, Jin JY, Li J, Zhao LY, Jin J, Liu YP, Song YW, Fang H, Chen B, Qi SN, Lu NN, Tang Y, Li N, Zhai YR, Zhang WW, Wang SL, Li YX. Jing H, et al. Among authors: tang y. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):922-932. doi: 10.1016/j.ijrobp.2022.10.030. Epub 2022 Nov 9. Int J Radiat Oncol Biol Phys. 2023. PMID: 36368434
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.
Sun GY, Zhang J, Wang BZ, Jing H, Fang H, Tang Y, Song YW, Jin J, Liu YP, Tang Y, Qi SN, Chen B, Lu NN, Li N, Li YX, Ying JM, Wang SL. Sun GY, et al. Among authors: tang y. Br J Cancer. 2023 Jun;128(11):2044-2053. doi: 10.1038/s41416-023-02218-w. Epub 2023 Mar 25. Br J Cancer. 2023. PMID: 36966236 Free PMC article.
Outcome measures of phase III anticancer drug trials in China.
Guo L, Huang H, Yu Y, Wang J, Wang L, Wang S, Wu D, Fang Y, Jiang N, Zhang S, Tang Y, Li N. Guo L, et al. Among authors: tang y. Chin Med J (Engl). 2023 Apr 20;136(8):992-994. doi: 10.1097/CM9.0000000000002264. Epub 2023 Apr 7. Chin Med J (Engl). 2023. PMID: 37026851 Free PMC article. No abstract available.
Clinical development of mRNA therapies against solid tumors.
Wu D, Hu L, Wang X, Yu Y, Jia SP, Huang HY, Li ZW, Ma JF, Zhu HB, Tang Y, Li N. Wu D, et al. Among authors: tang y. J Hematol Oncol. 2023 Jul 18;16(1):75. doi: 10.1186/s13045-023-01457-x. J Hematol Oncol. 2023. PMID: 37464375 Free PMC article.
Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018).
Shi Y, Chen H, Qin Y, Yang J, Liu P, He X, Zhou S, Zhou L, Zhang C, Song Y, Liu Y, Gui L, Wang S, Jin J, Fang H, Qi S, Li N, Tang Y, Wang X, Yang S. Shi Y, et al. Among authors: tang y. Cancer Pathog Ther. 2022 Oct 7;1(1):3-11. doi: 10.1016/j.cpt.2022.09.006. eCollection 2023 Jan. Cancer Pathog Ther. 2022. PMID: 38328609 Free PMC article.
Unveiling quality of clinical trial in China: from concern to confirmation.
Huang H, Hou Y, Fang H, Xu L, Yu Y, Zhang H, Zhang J, Tang Y, Lan G, Zhang W, Li N. Huang H, et al. Among authors: tang y. Cancer Commun (Lond). 2024 May;44(5):576-579. doi: 10.1002/cac2.12528. Epub 2024 Mar 6. Cancer Commun (Lond). 2024. PMID: 38446523 Free PMC article. No abstract available.
30,069 results
You have reached the last available page of results. Please see the User Guide for more information.